Posts From September, 2017

Dr. Pravin U. Dugel Elected to the Orbis International Board of Directors

September 26, 2017 – Phoenix – Dr. Pravin U. Dugel, managing partner, Retinal Consultants of Arizona – one of the nation’s leading Retina & Vitreous academic, clinical research and patient treatment facilities – has been elected to the Orbis International Board of Directors. Orbis International is a global nonprofit dedicated to addressing the tragedy of… Read More »


Retinal Research Institute First to Enroll, and the First Site in the World to Administer New Injection to Patients with AMD!

Graybug Vision Initiates Phase 1/2 Trial of GB-102 for Wet Age-related Macular Degeneration  – Novel Injectable Formulation for Potential Twice Per Year Treatment –  Redwood City, CA – September 19, 2017 – Graybug Vision, Inc., a clinical-stage, venture-held pharmaceutical company committed to developing potentially transformative therapies for vision-threatening diseases including wet (neovascular) age-related macular degeneration… Read More »



Promising Drugs in Pipeline Debut at Euretina 2017

Pravin U. Dugel, MD, Managing Partner, Retinal Consultants of Arizona; Clinical Professor, USC Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, California; Physician Executive Director, Phoenix Eye Institute, Banner University Medical Center, Phoenix, Arizona describes the promising new drugs coming up the pipeline at the 17th Euretina Congress in Barcelona, Spain. These include next generation drugs… Read More »



RCA Diabetes Support Group Program

Retinal Consultants of Arizona will offer a Diabetic Eye Disease Support Group program on November 18th. Our staff will be on hand to meet with you and answer all your questions about Diabetic Eye Disease. In the spirit of support groups, you will be able to meet others to learn from their experiences, or to… Read More »